Senior insider sale
EVP, Head of R&D at DIANTHUS THERAPEUTICS, INC. /DE/ — senior position signals high conviction
$5.22M
60.36K shares
What this filing means
RANDHAWA SIMRAT plans to sell 60.36K shares of DIANTHUS THERAPEUTICS, INC. /DE/ valued at approximately $5.22M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001950047-26-005356
Officer· EVP, Head of R&D
Since Mar 2026
60.36K
Shares to sell
$5.22M
Approx. market value
26.53K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/1/2026
26.53KTotal acquired26.53K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2026 | Exercise of Stock Options Cash | 26.53K | — |
| Total | 26.53K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
33.83K
Market value
$2.76M
3/12/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
26.53K
Market value
$2.47M
6/1/2026
Total
Units
60.36K
Value
$5.22M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/12/2026 | 33.83K | $2.76M | — | Completed |
| Planned — Approximate Date | ||||
6/1/2026 | 26.53K | $2.47M | NASDAQ | Planned |
| Total | 60.36K | $5.22M | ||